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Abstract
The low number of embryos obtained from IVM–IVF–IVC of prepubertal goat oocytes could be
due to an incomplete cytoplasmic maturation. Roscovitine (ROS) inhibits MPF and MAP kinase
activity and maintains the oocyte at Germinal Vesicle (GV) stage. The aim of this study was to
determine if meiotic activity is arrested in prepubertal goat oocytes cultured with 0, 12.5, 25, 50 and
100 mM of ROS for 24 h. A group of oocytes from adult goats was cultured with 25 mM of ROS to
compare the effect of ROS on prepubertal and adult goat oocytes. A sample of oocytes was stained to
evaluate the nuclear stage at oocyte collection time and after ROS incubation. IVM-oocytes not
exposed to ROS formed the control group. Prepubertal goat IVM-oocytes were inseminated and
cultured for 8 days. The percentage of oocytes at GV stage, after exposition to ROS was significantly
higher in adult goat oocytes (64.5%) than in prepubertal goat oocytes. No differences were found
among 25, 50 and 100 mM ROS concentrations (29, 23 and 26%, oocytes at GV stage, respectively).
After 8 days of culture, no differences in total embryos were observed between control oocytes and
oocytes treated with 12.5 and 25 mM (45.2, 36.1 and 39.4%, respectively), however the percentage of
blastocysts was higher in the control group. Western blot for the MAPK and p34cdc2 showed that both
enzymes were active in prepubertal goat oocytes after 24 h of ROS exposition. In conclusion, a low
percentage of prepubertal goat oocytes reached GV stage after ROS incubation; possibly because
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most of them had reinitiated the meiosis inside the follicle. ROS did not affect fertilization or total
embryos but ROS showed a negative effect on blastocyst development.
# 2005 Published by Elsevier Inc.
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1. Introduction
Goat oocytes, like other mammalian oocytes, are arrested at the diplotene stage of the
first meiotic prophase: the so-called germinal vesicle (GV) stage. During oocyte
maturation, the meiotical process reaches metaphase II stage (MII) where oocytes will be
arrested until fertilization or parthenogenetic activation. In vivo, mammalian oocytes
acquire cytoplasmic maturity (capacitation) and the competence to resume meiosis
(maturation) during follicle and oocyte growth [1,2]. Thus, both nuclear and cytoplasmic
maturation are required to ensure normal fertilization and embryo development. In vitro,
when fully grown oocytes are removed from their follicles to the culture medium they can
resume meiosis spontaneously despite cytoplasmic maturity.
In oocytes from prepubertal goats, although there is a high percentage (72%) of nuclear
maturation [3] the number of blastocysts obtained (<10%) is low [4]. A high percentage of
polyspermic fertilization and failure of male pronucleus formation has been observed in
IVM–IVF prepubertal goat oocytes, as has been observed in calf oocytes [5]. This is
attributed to an abnormal or incomplete cytoplasmic maturation of these oocytes.
Several authors have hypothezed that if oocytes are cultured in vitro, before maturation,
under conditions that maintain oocytes arrested at GV stage, they may have more chance of
completing the process of cytoplasm maturation [6–9]. The oocyte growth phase is
characterized by an increase in the synthesis and storage of proteins and RNA [10].
Mobilization of these stored products will be used for meiotic and early embryo
developmental events. The major changes that occur during oocyte maturation are related
to protein phosphorylation. Correlated with this burst of phosphorylation is the activation
of two major M-phases kinases: M-phase promoting factor (MPF) [11] and mitogen-
activated protein kinase (MAPK). MPF is a member of the cyclin dependent protein-
kinases. It is a heterodimer formed by two subunits: p34cdc2 (catalytic subunit) and cyclin B
(regulator subunit), which is a homologue of cdc13 in yeast [12]. During oocyte growth, the
inactive pre-MPF is phosphorylated at Thr 161, Thr 14 and Tyr 15 of p34cdc2. This
phosphorylation is partly catalyzed by the wee1 kinase [13]. During oocyte maturation,
MPF is activated by specific dephosphorylation of Tyr 15 catalyzed by the cdc25
phosphatase [14]. The other major group of enzymes implicated in oocyte maturation is the
MAPK family, also called extracellular signal-regulated kinases (ERKs). MAPK is formed
by at least two subunits (p42-ERK2 and p44-ERK1) [15]. In the oocyte, intracellular
signals like c-mos orc-ras directly activate MAPK or indirectly activate MEKinases, which
would activate MAPK, through phosphorylation, at the onset of oocyte maturation [16].
Independently of the differences between animal species, MPF and MAPK activation are
both important in oocyte maturation. Interference in any of these processes will inhibit
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MPF and MAPK activation, preventing resumption of meiosis and arresting the oocyte at
GV stage. Different pharmacological meiotic inhibitors have been studied, some of them
acting on protein synthesis, such as cyclohexamide [17], and others acting on
phosphorylation pathways, such as 6-dimethylaminopurine [17–19]. However, these
meiotic inhibitors caused a drastic loss in embryo developmental ability. Other treatments,
such as dibutyryl-cAMP (dbcAMP) or 3-isobutyl-1-methyl-xanthine (IBMX) molecules,
block bovine oocytes at GV by maintaining a high intracytoplasmic cAMP concentration,
but these treatments result only in a transient delay of meiotic resumption. Several authors
have used roscovitine as a meiotic inhibitor. Roscovitine is a purine known as a specific
inhibitor of cyclin-dependent protein kinases that prevents p34cdc2 dephosphorylation and
inhibits MPF kinase activity [20]. Meijer and Kim [20] showed that high concentrations of
roscovitine also act on MAPK activity. In fact, Motlik et al. [21] showed that the activation
of MAPK by okadaic acid was sufficient to trigger meiotic resumption in porcine oocytes
arrested at the GV stage by butyrolactone I (another MPF inhibitor). Roscovitine has been
successfully used to arrest meiotic activation without compromising further embryo
development in cattle [21,6] and pigs [22]. In horse oocytes [7], ROS did not affect early
embryo development of oocytes subjected to ICSI and cultured for 96 h. Ponderato et al.
[8,9] used a combination of roscovitine and butyrolactone I to arrest meiotic activation
without negative effects on the embryo development of cattle oocytes.
In goat oocytes, Ma et al. [23] observed that hypoxanthine was a concentration-related
meiotic inhibitor, but this inhibition declined gradually after 6 h of culture. Goat oocytes
underwent normal nuclear maturation following hypoxanthine inhibition but no results
were described for embryo development of these oocytes.
The aim of this study is to improve in vitro embryo development of prepubertal goat
oocytes, studying the effectiveness of roscovitine as a prematuration medium on meiotic
resumption and activity of MAPK and p34cdc2 of these oocytes.
2. Materials and methods
2.1. Oocyte collection
Oocytes from multiparous, adult goats were recovered from two goats previously
treated with sponges of FGA (lntervet, Salamanca, Spain) during 11 days and at day 9
injected with prostagladin F2a (Estrumate, Pitman-Moore, Madrid, Spain) and 5 mL of
porcine-FSH (Pluset, Calier, Barcelona, Spain) in three doses of 2, 2 and 1 mL at 12 h of
interval. At day 11, goats were slaughtered and ovaries were immediately transported to the
laboratory. Prepubertal goat (30–45 days old) ovaries were obtained from a commercial
slaughterhouse and transported to the laboratory within 2 h of slaughter.
The ovaries were rinsed in solution Dulbecco’s phosphate-buffered saline (PBS, P-
4417, Sigma Chemical Co., St. Louis, MO, USA) with 50 mg/mL of gentamycin sulphate
at temperature of 38.5 8C. The cumulus-oocyte complexes (COCs) of adult goats were
recovered by follicular aspiration of healthy follicles higher than 3 mm diameter. Oocytes
of prepubertalgoats were recovered by slicing in TCM199 (M-2520, Sigma), supplemented
with 2.2 mg/mL NaHCO3, 2% (v/v) steer serum (Donor Bovine Serum
1, CanSera, Ont.,
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Canada) and 50 mg/mL gentamycin at a temperature of 38.5 8C. Only COCs with at least
three intact layers of compact cumulus cells and homogeneous cytoplasm were selected.
Selected COCs were washed in TCM199.
2.2. In vitro prematuration (exposition of oocytes to ROS)
Groups of 25 COCs of prepubertal goats were cultured for 24 h at 38.5 8C under an
atmosphere of 5% CO2 in air with maximum humidity in 100 mL drops of TCM199 (M-
7528, Sigma) supplemented with 275 mg/mL sodium pyruvate (P-3662, Sigma), 146 mg/
mL L-glutamine (G-5763, Sigma), 50 mg/mL gentamycin and roscovitine (R-7772, Sigma)
at a concentration of 0, 12.5, 25, 50 and 100 mM as described by Mermillod et al. [6].
A group of 31 COCs of adult goats was cultured at the same conditions than those of
prepubertal goats with a roscovitine concentration of 25 mM.
2.3. In vitro maturation
After prematuration, prepubertal goat oocytes were transferred to 100 mL drops of
maturation medium: TCM199 (M-7528, Sigma) supplemented with 275 mg/mL sodium
pyruvate (P-3662, Sigma), 146 mg/mL L-glutamine (G-5763, Sigma), 10% (v/v) steer
serum, 10 mg/mL o-LH (L-5269, Sigma), 10 mg/mL o-FSH (Ovagen1, Immuno
Chemicals Products Ltd., Auckland, New Zealand), 1 mg/mL 17b estradiol (E-2257,
Sigma), 100 mM cysteamine (M-9768, Sigma) and 50 mg/mL gentamycin, and incubated
under mineral oil (M-3516, Sigma) for 27 h at 38.5 8C in a humidified air atmosphere of
5% CO2. Oocytes not prematured were considered control group.
2.4. Sperm preparation
Fresh ejaculates from three fertile males were taken to the laboratory at 38.5 8C. The
percentage of motility was assessed under an inverted microscope. Motile spermatozoa
were recovered by swim-up [24]. Seventy microliters of semen were placed in each of
several conical tubes under 2 mL defined medium modified by Younis et al. [25] and
referred to as mDM here, and incubated them for 1 h in a humidified atmosphere of 5%
CO2 in air at 38.5 8C. After incubation, 600 mL from the top of each tube was removed and
pooled in a sterile 15 mL centrifuge tube and centrifuged at 200  g for 10 min. After
discarding the supernatant, the resulting sperm pellet was resuspended 1:1 with mDM
medium containing ionomycin (I-0634, Sigma) and heparin (final concentration: 200 nM
of ionomycin and 10 mg/mL of heparin) and incubated for 15 min in a humidified air
atmosphere of 5% CO2 at 38.5 8C [26].
2.5. In vitro fertilization
After maturation, groups of 25 prepubertal goat oocytes were transferred into 100 mL
fertilization microdrops of modified Tyrode’s medium (TALP), as described by Parrish
et al. [24], supplemented with 1 mg/mL hypotaurine (H-1384, Sigma) under mineral oil.
After capacitation, sperm concentration was assessed with a haemacytometer, and an
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aliquot (5 mL) of the sperm suspension was added to the fertilization microdrops (final
concentration: 4  106 spermatozoa/mL). Gametes were cocultured for 24 h in a
humidified air atmosphere of 5% CO2 at 38.5 8C.
2.6. In vitro embryo culture
At 24 h post-insemination (hpi), in vitro fertilized oocytes were denuded.
Embryos were cultured in SOF medium ([27], modified by ref. [28]), groups of 18
oocytes were washed twice and placed into 25 mL drops of SOF. At 48 hpi, was added to
the drops 2.5 mL of FBS. Embryos were cultured at 38.5 8C in a humidified atmosphere of
5% CO2, 5% O2 and 90% N2.
2.7. Assessment of nuclear maturation, fertilization and embryo development
To evaluate the nuclear stage just after oocyte collection, after prematuration with
roscovitine and after 27 h of in vitro maturation, a sample of oocytes were mechanically
denuded, fixed in ethanol (90%):acetic acid (3:1, v/v) and, after 24 h, stained with 1%
lacmoid (L-7512, Sigma).
To evaluate the pronuclear stage after 17 h of IVF, a sample of oocytes were processed
in the same way as the oocytes fixed after prematuration and IVM. We considered oocytes
with a sperm tail in the cytoplasm to be fertilized and classified them in one of the next
three groups: 2PN (female pronucleus, male pronucleus and sperm tail; normal
fertilization), polyspermy (2 or more sperm tails in the cytoplasm with condensed heads
or two or more decondensed heads in the cytoplasm) and asynchrony (female pronucleus
and a condensed sperm head).
Embryos were assessed with fluorescent microscopy after Hoechst 33342 staining. The
percentage of total embryos (number of embryos obtained after 8 days of culture/oocytes),
morulae (embryos with 16 or more cells without blastocoele) and blastocysts (embryos
with 60 or more cells with blastocoele formation) was evaluated.
2.8. Gel electrophoresis
Prepubertal goat oocytes were denuded and separated in three groups of 120 oocytes
each one. Group 0 h: oocytes recovered after slicing; Group ROS 25: oocytes cultured for
24 h with 25 mM Roscovitine; Group IVM: oocytes matured for 27 h. A sample of
granulosa cells (GC) was used as a positive control of the procedure and also to normalize
the results. The cells were lysed by sonication and polypeptides were separated using 10%
SDS polyacrilamide gel electrophoresis as described by Laemmli [29]. Also markers of
known weight were used as a control.
2.9. Immunoblotting
The electrophoretically separated polypeptides were transferred to a nitrocellulose sheet
[30] and blocked by incubation in PBS 0.05% Tween-20 with 3% of BSA for 30 min.
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Sheets were incubated with the first antibodies: MAPK (C-14 Santa Cruz
Biotechnology, CA), MAPKP (K-23, Santa Cruz Biotechnology) (1/2000), p34cdc2
(sc-54, Santa Cruz Biotechnology) and p34cdc2Tyr-P (sc-7989-R, Santa Cruz Biotechnol-
ogy) (1/200) for a minimum of 1 h. Then, they were washed in PBS 0.05% Tween-20 for
15 min and incubated in the same buffer containing the anti-rabbit (sc-2007, Santa Cruz
Biotechnology) or anti-mouse IgG (sc-2008, Santa Cruz Biotechnology) antibody (1/5000
and 1/2000, respectively) for 30 min.
The activity of these proteins was revealed using a blotting chemiolluminiscence
detection kit (Supersignal West Dura Extended Duration Substrate of PIERCE) [31].
Experiments were done in triplicate.
2.10. Statistical analysis
Differences in results were assessed using Chi-square test (x2) or Fisher test (Graph-Pad
Software, San Diego, CA, USA). Differences with a P < 0.05 were considered statistically
significant.
Intensity of the bands on Western blots was measured by a densitometric analysis
system: BIO-RAD by the software Quantity One. Differences in results were analyzed by
ANOVA test. Differences at P < 0.05 were considered to be statistically significant.
2.11. Experimental design
Experiment 1: The aim of this experiment was to analyze the effect of different ROS
concentrations (0, 12.5, 25, 50 and 100 mM) on nuclear arrest of prepubertal goat
oocytes. A sample of adult oocytes was used as control to test the effectiveness of the
ROS. A sample of prepubertal goat oocytes was analyzed, at time of oocyte collection,
in order to test the effectiveness of ROS treatment.
Experiment 2: The aim of this experiment was to analyze embryo development of
prepubertal goat oocytes prematured with ROS. According to the results of the
experiment 1, at experiment 2 oocytes were prematured with 0, 12.5 and 25 mM of ROS
concentrations.
Experiment 3: According to the results of the experiments 1 and 2, the objective of this
experiment was to analyze, by western blot, the effect of ROS on MAPK and p34cdc2 of
prepubertal goat oocytes.
3. Results
3.1. Experiment 1
Table 1 shows that 64% of adult goat oocytes exposed for 24 h to 25 mM roscovitine
present GV nuclear stage. However, this concentration of roscovitine was notable to block
meiosis in prepubertal goat oocytes. After 24 h of ROS exposition, the percentage of
prepubertal goat oocytes at GV stage was 16.9, 28.7, 23.1 and 26.5% for 12.5, 25, 50 and
100 mM ROS concentrations, respectively.
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After oocyte collection, 153 oocytes of prepubertal goat oocytes were denuded and
stained to assess nuclear stage. Of these oocytes, 11 (7.2%) were at GV stage, 113 (73.8%)
were at GVBD stage, and 19 (12.4%) and 10 (6.5%) were at MI and MII stage,
respectively.
3.2. Experiment 2
After IVM (Table 2), the percentage of prepubertal goat oocytes at MII was significantly
(P < 0.05) higher in control group oocytes (74.4%) than in oocytes exposed to 0, 12.5 and
25 mM ROS for 24 h and subsequently matured for 27 h (54.8, 62.5 and 52.0%,
respectively).
Table 3 shows the results of IVF of prepubertal goat oocytes exposed to ROS for 24 h
prior to IVM. The percentage of oocytes sperm-penetrated (total fertilized oocytes) was
higher in oocytes prematured without ROS than oocytes at control group (48.5% versus
27.5%). No differences were found among ROS groups (12.5 and 25 mM) and control
oocytes in any of the parameters analyzed.
Table 4 shows the results of embryo development after 8 days of in vitro culture. The
percentage of total embryos obtained from oocytes exposed to ROS 12.5 and 25 mM and
from oocytes at control group did not show differences (36.1, 39.4 and 45.2%,
A.R. Jimenez-Macedo et al. / Theriogenology xxx (2005) xxx–xxx 7
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Table 1
Effect of 24 h of prematuration with roscovitine in meiosis inhibition of adult and prepubertal goat oocytes
(replicates = 7)
Treatment Total oocytes GV (%) GVBD (%) MI (%) MII (%)
Prematuration
ROS 0 mM 119 8 (6.7)d 5 (4.2) 50 (42.0) 56 (47.0)a
ROS 12.5 mM 124 21 (16.9)c 11 (8.9) 53 (42.8) 39 (31.4)b
ROS 25 mM 101 29 (28.7)b 10 (9.9) 41 (40.6) 21 (20.8)b
ROS 50 mM 104 24 (23.1)bc 7 (6.7) 42 (40.4) 31 (29.8)b
ROS 100 mM 98 26 (26.5)bc 2 (2.1) 48 (49.0) 22 (22.4)b
Oocytes of adult goats
with ROS 25 mM
31 20 (64.5)a 2 (6.4) – 9 (29.1)b
ROS: roscovitine; GV: germinal vesicle; GVBD: germinal vesicle breakdown; MI: metaphase I; MII: metaphase
II. Different letters (a–d) within a column are significantly different (x2, P < 0.05).
Table 2
Nuclear stage of in vitro matured prepubertal goat oocytes prematured with roscovitine (replicates = 7)
Treatment Total oocytes GV (%) GVBD (%) MI (%) MII (%)
Maturation
Control 121 1 (0.8) 2 (1.6) 28 (23.1) 90a (74.4)
ROS 0 mM 124 2 (1.6) 2 (1.6) 49 (39.5) 68b (54.8)
ROS 12.5 mM 136 6 (4.6) 6 (4.6) 39 (28.7) 85b (62.5)
ROS 25 mM 125 12 (9.6) 18 (14.4) 31 (24.8) 65b (52.0)
ROS: roscovitine; GV: germinal vesicle; GVBD: germinal vesicle breakdown; MI: metaphase I; MII: metaphase
II. Different letters (a and b) within a column are significantly different (x2, P < 0.05).
UN
CO
RR
EC
TE
D 
PR
OO
F
respectively). However, the percentage of blastocysts was higher at control group (5%)
than in prematured groups.
3.3. Experiment 3
Determination of MAPK and p34cdc2 in prepubertal goat oocytes.
Figs. 1 and 2 show the results obtained by western blot for the total and active MAPK
(phosphorylated form) and for the total and inactive p34cdc2 (Tyrosin phosphorylated form)
in granulosa cells, immature oocytes (0 h), in vitro matured oocytes for 27 h (IVM) and
oocytes exposed to 25 mM of roscovitine for 24 h (ROS 25).
Results of western blots show bands with the same intensity for immature oocytes
(Group 0 h) and in prematured and IVM-oocytes (groups ROS 25 and IVM, respectively)
(Fig. 1, lanes 3–5). MAPK activity was detected in oocytes exposed to ROS and IVM-
oocytes (groups ROS 25 and IVM) (Fig. 1, lanes 8 and 9) but in immature oocytes the
intensity of the band was lighter (Fig. 1, lane 7).
Fig. 2 revealed that the intensity of the bands in total p34cdc2 was similar in immature
(Group 0) and cultured oocytes (Groups ROS 25 and IVM) (lanes 4, 2 and 3). A strong
band of inactive p34cdc2 (Tyrosin phosphorylated form) was found in immature oocytes
(lane 9) and a lighter or mostly inapreciable one in oocytes of groups ROS 25 and IVM
(lanes 7 and 8).
The densitometric analysis shows that it does not exist differences neither in total
MAPK or total p34 among oocyte groups (0 h: 0.8646  0.06669 versus 0.4618 
0.05437; ROS 25: 0.8788  0.02006 versus 0.4876  0.02057; IVM: 0.8705  0.1185
A.R. Jimenez-Macedo et al. / Theriogenology xxx (2005) xxx–xxx8
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Table 4
Embryo development at day 8 post-insemination of prepubertal goat oocytes prematured with ROS prior to IVM
(replicates = 5)
Inseminated
oocytes
Total embryos 2–7-cell 8–16-cell Morulae Blastocysts
Control 221 100 (45.2)a 50 (22.6)b 15 (6.8) 3 (1.3) 11 (5.0)a
ROS 0 200 63 (31.5)b 70 (35.0)a 11 (5.5) 2 (1.0) 0
ROS 12.5 260 94 (36.1)ab 86 (33.1)a 17 (6.5) 3 (1.1) 0
ROS 25 231 91 (39.4)ab 83 (35.9)a 18 (7.8) 6 (2.6) 1 (0.4)b
Different letters (a and b) within a column are significantly different (x2, P < 0.05).
Table 3
In vitro fertilization of oocytes cultured with ROS prior to IVM (replicates = 7)
Treatment Total inseminated
oocytes
Total fertilized (%) 2PN (%) PS (%) ASINC (%)
Control 69 19b (27.5) 17 (24.6) 2b (2.9) 0 (0)
ROS 0 mM 66 32a (48.5) 16 (24.2) 13a (19.6) 3 (4.5)
ROS 12.5 mM 70 17b (24.3) 13 (18.6) 4b (5.7) 0 (0)
ROS 25 mM 76 27ab (35.5) 19 (25.0) 3b (3.9) 5 (6.6)
ROS: roscovitine; 2PN: 2 pronuclei; PS: polyspermic; ASINC: asyncronic development of 2PN. Different letters
(a–c) within a column are significantly different (x2, P < 0.05).
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versus 0.5083  0.0507, respectively); but we found statistically significant differences
among immature oocytes (0 h) and groups ROS 25 and IVM for the MAPKP
(0.006033  0.001222 versus 0.7513  0.0565 and 0.8039  0.06775, respectively)
and the p34cdc2 Tyr-P (0.6078  0.04127 versus 0.01393  0.01421 and 0.0750 
0.009315, respectively).
We found that both p34cdc2 and MAPK activity was lower in group 0 h than in ROS 25
and IVM as it could be expected but roscovitine, at the concentration used in this study, has
been unable to block the activity of p34cdc2 and MAPK.
4. Discussion
In this study, we demonstrated the effectiveness of roscovitine in arresting adult goat
oocytes at nuclear GV stage. The low percentage of prepubertal goat oocytes at GV stage
after ROS incubation could be due to the fact that a high percentage of oocytes have already
resumed meiosis before ROS exposition. Treatment of prepubertal goat oocytes with
roscovitine for 24 h prior to maturation did not affect normal fertilization (2PN zygotes) or
total embryos produced at 8 days post-insemination, while it resulted in a reduced
blastocyst formation. Moreover, assessing MAPK and p34cdc2 activity using Western blot
A.R. Jimenez-Macedo et al. / Theriogenology xxx (2005) xxx–xxx 9
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Fig. 1. Western blot for total MAPK (ERK 1 and ERK 2) (lanes 2–5) and active MAPK (lanes 6–9) for granulosa
cells (GC), immature oocytes (0 h), oocytes prematured with roscovitine 25 mM (ROS 25) and in vitro maturated
oocytes (IVM) of prepubertal goats. Marker (M).
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we did not find differences between oocytes matured for 27 h (IVM-oocytes) and oocytes
exposed to ROS for 24 h. Differences in MAPK and p34cdc2 activity were found between
oocytes at collection time (0 h) and cultured oocytes.
Different concentrations of roscovitine were used to block meiosis activation in pig
(50 mM: [32,33]; 80 mM: [34]; 25 and 50 mM: [22]); cow (25 mM: [6]); calf (25 mM:
[35,36]); horse (66 mM: [7]). In our study, we have tested concentrations of 12.5, 25, 50 and
100 mM. A concentration of 25 mM was the optimal dosis to arrest meiosis without
detrimental effect on embryo development. However, blastocyt development was reduced
in all of the prematured oocytes (0, 12.5 and 25 mM) compared to control oocytes (3.0, 1.0,
1.1% versus 6.3%, respectively). Furthermore, a degenerative effect was observed in
oocytes exposed to 50 and 100 mM ROS (data not presented). In these two groups, a high
percentage of oocyte degeneration was observed during embryo culture (N = 104 and
N = 98; 75.5 and 72.8%, respectively). Based on these results, the groups of ROS 50 and
100 mM were eliminated from the rest of experiments. In our study, roscovitine did not
affect in vitro fertilization. The lack of effect of roscovitine on meiosis arrest could be
caused because oocytes recovered from ovaries of prepubertal goats slaughtered in a
commercial abattoir had reinitiated the meiosis inside follicle or were ready to mature after
follicle liberation. The low percentage of oocytes at GV after oocyte collection (7.2%)
compared to oocytes exposed to ROS (29%) could be explained because the longer time
needed to denude and stain the oocytes compared to exposing the oocytes to ROS. Franz
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Fig. 2. Western blot for total p34cdc2 (lanes 1–4) and p34cdc2 tyr-P (lanes 6–9) for granulosa cells (GC), immature
oocytes (0 h), oocytes prematured with roscovitine 25 mM (ROS 25) and in vitro maturated oocytes (IVM) of
prepubertal goats. Marker (M).
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et al. [7] observed lower percentages of GV horse oocytes, after roscovitine exposition for
24 h, in expanded COCs than in compact COCs (57 and 84%, respectively). These authors
suggest that a proportion of oocytes with expanded cumuli at the time of oocyte collection
were already maturing or ready to mature if removed from the follicle, and thus roscovitine
was less effective in suppressing meiosis.
In the present study, we did not find differences in total, normal (oocytes with 2
pronuclei) or polyspermic fertilization between prematured and control oocytes.
Concentrations of meiotic inhibitors affect meiosis resumption. In cattle oocytes,
Mermillod et al. [6], testing different concentrations of roscovitine (12.5, 25, 50 and
100 mM), concluded that doses higher than 25 mM increased rates of oocytes blocked at the
GV stage compared to 12.5 mM. These authors concluded that 12.5 mM was effective in
inhibiting MPF activity, but not effective in inhibiting MAPK activity; thus, allowing
oocytes to resume meiosis and progress to MI. Higher doses of roscovitine are also active in
inhibiting MAPK activity [20].
Roscovitine inhibits MPF activity, blocking the p34cdc2 subunit of MPF cattle oocytes
[6] and also decreases enzyme activity of MAP kinase in pig oocytes [32]. Other authors
have found that during prematuration of calf oocytes with roscovitine, several events such
as protein synthesis and most of the modifications of protein phosphorilation (Akt/PKB,
JNK1/2 and Aurora-A) are not affected by escape to roscovitine prevention [37]. Moreover,
there are other two proteins (48 and 64 kDa), which are specific to matured oocytes which
were not blocked in cattle in oocytes prematured with ROS [38]. That suggests that there
are alternative pathways in oocyte maturation that this kind of meiotic inhibitor cannot
block over. That partial arrest of the events concerning to maturation, could explain the
abnormal acceleration of maturation observed after this treatment [38].
In our study, oocytes from prepubertal goats exposed for 24 h to roscovitine did not
arrest meiosis, possibly because meiosis was already re-initiated. Western blot analysis
shows that the activity of p34cdc2 and MAPK was detected in oocytes exposed to
roscovitine for 24 h at a similar intensity as in in vitro matured oocytes for 27 h and higher
than the activity of oocytes at collection time. Although oocytes at collection time had
reinitiated the meiosis, most of them were at GVBD stage. At this early stage of GVBD, the
MPF and MAPK activity starts to rise but they do not reach their highest levels until MI.
MPF activity is high at MI and rise at MII. MAPK activity remain high since MI until
fertilization. The percentage of oocytes at MI and MII nuclear stage was 40.6 and 20.8% of
ROS incubated oocytes and 23.1 and 74.4% of IVM-oocytes and 12.4 and 6.5% of oocytes
at collection time. These different results in nuclear maturation would explain the
differences in MPF and MAPK activity among oocyte groups.
In goat oocytes, Dedieu et al. [39] have studied the presence of total p34cdc2. They
detected that total p34cdc2 remained stable during the whole process of maturation from the
GV to the MII stage. However, they did not find this protein in meiotically incompetent
oocytes.
Prepubertal goat oocytes, independently of the oocyte and sperm treatment used,
show a low embryo developmental competence. Salamone et al. [40] observed the
kinetics of MPF and MAPK activity during oocyte maturation in calf and cow oocytes,
concluding that kinase activity was low at the GV stage (0 h) and increased several fold
at 24 h after maturation in both oocytes groups. Although the amount of kinase activity
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increased in calf oocytes during maturation, the total activity of MPF and MAPK
remained significantly lower than that observed in cow oocytes. These authors
concluded that these deficiencies may lead to anomalous ooplasmic maturation
and may result in the production of developmentally incompetent oocytes. In our study,
we have observed the kinetic activity of MPF and MAPK, but we do not know
the degree of these activities, which were possibly as low as those observed in calf
oocytes.
According to the results of this experiment, roscovitine was able to block meiosis of
adult goat oocytes. Oocytes from prepubertal goats had reinitiated the meiosis before
follicular liberation, thus roscovitine was ineffective in blocking meiosis, although these
oocytes were fertilized at the same rate as control oocytes. At the time of collection, in spite
of oocytes had reinitiated meiosis, they presented inactive p34cdc2 and MAPK, these
enzymes were activated during IVM and ROS exposition.
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